Cerebrospinal fluid biomarkers in multiple sclerosis.

Hayrettin Tumani1, Hans-Peter Hartung, Bernhard Hemmer

  • 1Department of Neurology, University of Ulm, Oberer Eselsberg 45, Ulm D-89081, Germany. hayrettin.tumani@uni-ulm.de

Summary

Identifying biomarkers in cerebrospinal fluid (CSF) is crucial for understanding multiple sclerosis (MS) progression and treatment. CSF analysis offers specific insights into MS pathology beyond imaging.